7 min read
Filed by: Tenisha Manning, Founder – CW Alliance
What’s happening:
Your test comes back abnormal. The abnormality is real. The numbers are there. But the provider interprets the abnormality as meaningless. “This is just normal variation.” “It’s not clinically significant.” “These numbers are borderline.” The abnormality is documented, but the interpretation dismisses it. The finding is acknowledged, but the meaning is denied. The data exists, but the significance is erased by interpretation.
Why it matters:
Reading a test result is not the same as understanding it. A provider can see the abnormality and still misinterpret what it means. They can read the numbers and still reach the wrong conclusion. They can document the finding and still act as if it doesn’t matter. Abnormal is abnormal. Borderline is not normal. Variation that differs from your previous baseline is a change. When providers interpret abnormal findings as insignificant, they create a dangerous permission structure: permission to ignore, permission to wait, permission to act as if nothing has changed.
What to do differently:
When a test comes back abnormal, don’t accept “insignificant” as an answer. Ask: What does this abnormality mean? How does it compare to my previous results? What is the plan to investigate or monitor it? Don’t let the provider’s interpretation override your body’s data. Push back on dismissals. Get a second opinion. Demand that abnormal findings receive appropriate attention, investigation, or monitoring. Your job is to make sure the abnormality is not erased by interpretation.
Your appointment is routine. Annual physical. Blood work ordered. You answer the questions. Height. Weight. Any new symptoms? No. Everything’s fine.
Two weeks pass.
A message appears in your patient portal: “Your lab work is back. Your provider wants to see you to discuss the results.”
Your heart jumps. Discuss? That usually means something.
You call and get in three days later.
The provider sits down with the lab printout. “Your thyroid panel came back abnormal,” they say.
Abnormal. The word hangs there.
“Your TSH is elevated. It’s 8.2.”
You write it down. TSH. 8.2. You ask what it means.
“It’s slightly elevated,” the provider says. “But it’s not clinically significant. We see numbers like this all the time. It’s probably just normal variation for you.”
Normal variation.
You ask if you should be tested again. Monitored.
“Not yet,” the provider says. “Let’s recheck in a year at your next physical. If it stays elevated, we’ll talk about treatment.”
You leave confused. Abnormal, but not significant? Elevated, but not worrisome? A year?
Six months later, you develop symptoms. Fatigue that doesn’t improve with sleep. Weight gain despite no dietary changes. Joint pain. Brain fog. You call your doctor.
“These could be a lot of things,” the provider says. “Probably stress. Try managing your stress and come back in a few months if it doesn’t improve.”
Four months later, the symptoms have worsened. You’re exhausted. You go back to your doctor and demand testing.
New bloodwork is ordered.
Your TSH is now 12.5. Your thyroid antibodies are elevated. Very elevated. You have autoimmune thyroiditis. Full-blown. Requiring medication.
You confront your provider: “You said the first TSH of 8.2 was not clinically significant. It was the beginning of this.”
“That was borderline,” your provider says. “We couldn’t have predicted this progression.”
But your body predicted it. Your body was sending signals. The test captured the signal at 8.2. And it was dismissed. Interpreted as insignificant. Written off as normal variation.
Six months of progression that could have been caught. Six months of waiting. Six months of your autoimmune system attacking your thyroid while everyone assured you it wasn’t important.
The signal: The abnormality was real. The interpretation was wrong.
What happens when abnormal tests are interpreted as insignificant:
A provider receives a test result that deviates from normal. The provider sees the number. Acknowledges it’s outside the standard range. But then interprets it as “not clinically significant.” “Borderline.” “Normal variation.” “Nothing to worry about.”
The abnormality exists. The interpretation erases its meaning.
This is not the same as a normal test misread as abnormal. This is an abnormal test correctly identified as abnormal—but then reinterpreted as meaningless.
The provider is reading the data. But failing to understand what the data is saying.
The pattern across cases:
When abnormal tests are interpreted as insignificant:
The provider acknowledges the abnormality exists
The provider makes a judgment that it’s not serious
No investigation is pursued
No monitoring plan is created
No follow-up is scheduled
Time passes
Disease progresses
Later investigation reveals the abnormality was the beginning of something serious
Earlier attention would have changed the timeline, treatment options, or severity
When abnormal tests are interpreted appropriately:
The provider acknowledges the abnormality
The provider recognizes that abnormal means something has changed
A plan is created: investigate, monitor, or refer
Baseline is established
Future changes are measured against that baseline
Early disease progression is caught
The difference is the interpretation. And interpretation matters more than most providers understand.
Matthew 16:3 teaches: “Ye can discern the face of the sky; but can ye not discern the signs of the times?” You know how to read simple signs. You can predict weather. But can you read the signs in front of you? The provider can read the test. But can they read what the test is telling them? Can they interpret correctly? A test result is a sign. To see it and misinterpret it is to have eyes but not see.
Mokokoma Mokhonoana observed: “Reading, seeing, and hearing happen way more often than understanding.” The provider reads the abnormal test. They see the elevated number. They hear that it’s abnormal. But do they understand what it means? Understanding requires going deeper than reading. It requires connecting the abnormal result to the patient’s symptoms, to the disease process, to what will happen if the abnormality progresses.
Research on diagnostic errors shows that misinterpretation of test results—not misreading, but misinterpretation—is a significant cause of delayed diagnosis. One documented case illustrates this pattern: A patient presented to the Emergency Department with chest pain radiating to his left arm and face. An EKG was performed and revealed “diffuse ST changes.” A second EKG one year later, after a reported chest pain episode, showed significant ST changes compared to the prior EKG—changes indicating a heart attack had occurred. However, the provider misinterpreted the abnormal EKG, stating that the changes were “unchanged from the prior EKG” and therefore not significant. The provider documented this interpretation and ordered no further cardiac workup. No cardiac enzymes were drawn. No cardiologist was consulted. The patient was instructed to follow up with his primary care physician.
Based on this misinterpretation, no treatment was provided for what the abnormality actually indicated: an acute cardiac event. Nearly one year later, the patient suffered an ischemic stroke with significant cognitive deficits. He was unable to return to his career in the financial industry. The case was settled for $2.25 million. Medical experts testified that had the abnormal EKG been correctly interpreted and appropriate cardiac workup been performed, the patient would have received timely treatment, preventing the subsequent stroke and cognitive injury.
Research on thyroid disease specifically shows that providers frequently misinterpret borderline TSH elevations as “not clinically significant” or “normal variation.” Studies document that many patients with TSH levels between 4.5 and 10 mIU/L—considered “subclinical hypothyroidism”—experience progression to overt hypothyroidism within 2-5 years. Interpreting these early elevations as insignificant can delay diagnosis and allow autoimmune thyroid disease to progress undetected. The pattern is consistent: abnormal is interpreted as normal, early disease is treated as no disease, and by the time significant abnormality appears, intervention is more complex and outcomes are worse.
The pattern is consistent: Abnormal tests interpreted as insignificant become tomorrow’s advanced disease.
Why Abnormal Tests Are Interpreted As Insignificant
Let me explain what’s happening structurally.
Providers confuse “abnormal by lab standards” with “clinically significant.”
A test result comes back outside the normal reference range. Technically, it’s abnormal. But the provider makes a judgment call: “This is not clinically significant to this patient at this time.”
This judgment can be correct. A single elevated white blood cell count in an otherwise healthy person might not be significant. A minor deviation from normal in an asymptomatic patient might not require intervention.
But the problem is that providers often apply this reasoning when it’s not appropriate. When the abnormal result is the first signal of emerging disease. When the abnormality is part of a pattern. When the deviation from normal is significant for that particular patient’s baseline.
Providers over-rely on “normal reference ranges” instead of individual baselines.
Lab reference ranges are based on population statistics. “Normal” is usually defined as the middle 95% of a healthy population. But normal for the population is not the same as normal for an individual.
A patient’s TSH might be 3.5 at one visit and 8.2 at the next. The reference range says anything under 4.5 is normal. So technically, 8.2 is abnormal. But if that patient has always had a TSH of 3.0-3.5, a jump to 8.2 is a significant change for them—even if 8.2 is “normal” for someone else.
Good providers recognize this. They look at the individual’s baseline and see the change. They recognize that change is more important than absolute value.
But many providers look only at the reference range. “It’s in the abnormal range, but it’s close to normal, so it’s probably fine.”
Providers minimize findings they don’t know what to do with.
A provider sees an abnormal result. But they don’t know what it means for this patient. They don’t know what to order next. They don’t know if intervention is necessary.
Rather than admit uncertainty and refer to a specialist, they minimize the finding. “Probably not significant. Let’s watch it.” They create the appearance of action (monitoring) without actual investigation.
Good providers understand that abnormal demands attention.
A truly competent provider sees an abnormal result and asks: What does this mean for this patient? Why is it abnormal? What will it become if untreated? What’s my plan?
They might conclude: “This is truly not significant for this patient. Here’s why. Here’s what I’ll monitor. Here’s when I’ll reassess.”
But they don’t erase the abnormality. They don’t pretend it’s normal. They don’t dismiss it.
But many providers—even well-intentioned ones—misinterpret abnormal findings as insignificant and move on. And when disease progresses, they’re surprised.
This is a system design problem. But it costs you health.
CLUE™ is how you recognize when an abnormal test is being misinterpreted as insignificant and how you demand appropriate attention.
The signal appears when a provider tells you your test is abnormal but says it’s “not clinically significant.”
You’ll recognize it by:
Provider says the result is “slightly abnormal” or “borderline”
Provider says “this is normal variation” or “normal for some people”
Provider says “we see this all the time” without explaining why it doesn’t matter
Provider doesn’t create a monitoring plan or follow-up schedule
Provider doesn’t investigate further despite the abnormality
Provider offers reassurance without explanation
You leave confused about whether to worry
Provider doesn’t compare the result to your previous baseline
Provider doesn’t ask whether you have symptoms that might relate to the abnormality
You push back and ask questions, but the provider’s answers are vague
A dismissing provider says: “It’s abnormal, but not significant. Don’t worry about it.”
A responsible provider says: “This result is abnormal. Here’s what it might mean. Here’s how it compares to your previous results. Here’s the plan for monitoring or investigating it. Here’s when we’ll reassess.”
The difference is explanation.
Across your medical visits:
The pattern of abnormal results interpreted as insignificant means:
Abnormal findings are acknowledged but minimized
No investigation is pursued
No monitoring plan is created
No baseline is established
You’re confused about the significance
Disease progresses silently
Later testing reveals advanced disease
The pattern of abnormal results interpreted appropriately means:
Abnormal findings are explained
A plan is created (investigate, monitor, or refer)
Baseline is documented
You understand what it means and what happens next
Early disease progression is caught
The pattern reveals whether abnormality is being respected or erased.
The medical system emphasizes not over-treating, not over-testing, not creating unnecessary anxiety. This is appropriate in many cases. But it creates a blind spot: the assumption that if something is only “slightly abnormal,” it doesn’t matter.
But slight abnormality is still abnormality. It’s just abnormality at an earlier stage. And early abnormality, appropriately recognized and monitored, can prevent advanced disease.
Women who maintain their health understand this early:
Abnormal is not normal. Borderline is not fine. Variation that differs from your baseline is a change. Changes demand explanation.
They don’t accept “not significant” as an answer. When a provider says an abnormal test is insignificant, they ask:
Why is it abnormal if it’s not significant?
How does it compare to my previous results?
What would make it significant?
What’s the plan if it stays abnormal?
Should I have symptoms related to this?
They demand that abnormal findings receive appropriate interpretation, not dismissal. They understand that their job is to make sure the provider’s interpretation matches the reality of the data.
This understanding is embedded in the USU framework: Abnormal is a signal. Interpretation is where the signal gets lost. You are responsible for making sure the signal is not erased by misinterpretation.
A provider can correctly read a test result—can see that it’s abnormal—and still misinterpret what that abnormality means. Reading is not understanding. Seeing is not interpreting. The ability to read numbers does not guarantee the ability to understand what those numbers are telling you.
Here’s what matters: When a test comes back abnormal, that abnormality deserves appropriate interpretation. Not dismissal. Not reassurance without explanation. Interpretation. What does it mean? How serious is it? What’s the plan?
Providers who understand this don’t erase abnormal findings. They investigate them. They monitor them. They create plans around them. They explain them to the patient.
But many providers, facing pressure to minimize findings and avoid unnecessary testing, interpret abnormal results as insignificant and move on. And when disease progresses from early stage to advanced stage, they’re surprised.
You deserve better. You deserve interpretation grounded in your individual baseline, your symptoms, and your risk factors. You deserve to have abnormal findings treated as what they are: signals that something has changed.
Your symptoms don’t fit the provider’s expectations of what a disease should look like. You’re young, so you probably don’t have heart disease. You’re thin, so you probably don’t have diabetes. You’re calm, so you probably don’t have anxiety. The provider’s assumptions about your profile override what your body and your tests are telling them. The diagnosis is determined not by your data, but by how well you match the provider’s expectation of what a person with this condition should look like.
Stay aware. Stay ready. Stay impossible to dismiss.
— USU
Next week: Issue #24
Diagnostic assumptions based on patient profile. When who you are becomes more important than what your symptoms are.
The Unusual Symptom Unit Podcast — Coming Summer 2026
High-production case file investigations into the medical cases that fall through the cracks. Real frameworks you can use now. Real cases coming soon.
The Hybrid Journal — Waitlist Open
Your symptoms live in your body. Your records live in five different portals. That gap costs women critical time. The journal I'm building closes it—SDI™ tracking with carbon copy pages for your doctor, portal navigation tools, and space to own your full health story. Be the first to know when the waitlist is open by sending an email to: info@cw-alliance.com.
P.S. Abnormal means something has changed. Interpret it, don’t erase it. Your body is more honest than any provider’s interpretation. Trust the data. Demand the explanation.
About USU Dispatch: Weekly investigative health intel from the Unusual Symptom Unit. This dispatch series examines the thirty patterns between unusual symptoms and medical dismissal. The podcast—launching Summer 2026—will investigate the cases, the women, and the solutions.
Subscribe to USU Dispatch™
Weekly investigative health intel that helps you document clearly, speak with precision, and become impossible to dismiss in the medical system.
USU Dispatch™
Intelligence for women navigating medical uncertainty
© CW Alliance, LLC